行情

CPHI

CPHI

中国医药控股
AMEX

实时行情|Nasdaq Last Sale

0.7725
+0.0125
+1.64%
交易中 10:15 06/15 EDT
开盘
0.7697
昨收
0.7600
最高
0.7749
最低
0.7697
成交量
24.55万
成交额
--
52周最高
1.630
52周最低
0.3200
市值
3,366.52万
市盈率(TTM)
-11.4785
分时
5日
1月
3月
1年
5年
惠普森医药公司(CPHI.US)Q1营收240万美元，同比增长33.7%
智通财经网 · 05/17 06:16
BRIEF-China Pharma Holdings Posts Q1 Loss Per Share Of $0.02
reuters.com · 05/14 21:22
China Pharma Holding Q1每股收益（$ 0.02），同比不变，销售额从去年同期的176万美元增长为240万美元
China Pharma Holding (AMEX:CPHI) reported quarterly losses of $(0.02) per share. This is unchanged from the same period last year. The company reported $2.40 million in sales this quarter. This is a 36.05 percent
Benzinga · 05/14 20:31
在第一季度收入增加的情况下，中国医药控股公布净亏损
MT Newswires · 05/14 16:51
-Earning Flash（CPHI）CHINA PHARMA HOLDINGS报告第一季度收入为240万美元
MT Newswires · 05/14 16:44
中国医药预计与海南自由贸易港相关的增长机会将大幅增加
HAIKOU, China, April 19, 2021 /PRNewswire via COMTEX/ -- HAIKOU, China, April 19, 2021 /PRNewswire/ -- China Pharma Holdings, Inc. (NYSE American: CPHI)...
PR Newswire - PRF · 04/19 12:30
艾德证券期货：料日内恒指高位震荡 百融云、美佳音今日暗盘
新浪证券 · 03/30 02:22
午后市场动态：道琼斯指数上涨50点；道指上涨50点。酶消化率下降
Toward the end of trading Monday, the Dow traded up 0.16% to 33,123 while the NASDAQ fell 0.68% to 13,050.03. The S&P also fell, dropping 0.13% to 3,969.25.
Benzinga · 03/29 18:34
更多
财务预测
暂无数据
利润表更多
净利润（美元）
同比（%）
资产负债表更多
总资产（美元）
总负债（美元）
资产负债率（%）
现金流表更多
经营现金流（美元）
同比（%）
了解CPHI最新的财务预测，通过CPHI每股收益，每股净资产，每股现金流等数据分析中国医药控股近期的经营情况，然后做出明智的投资选择。
暂无数据
  • 业绩
  • 资产分布
  • 分红历史
暂无数据
所属板块
生物技术和医学研究
-1.10%
制药与医学研究
-0.60%
高管信息
Chairman/President/Chief Executive Officer/Chief Financial Officer/Director
Zhilin Li
Director
Heung Tsui
Independent Director
Gene Bennett
Independent Director
Baowen Dong
Independent Director
Yingwen Zhang
暂无数据
  • 全部
  • 财务报告
  • 内部人交易
更多
CPHI 简况
China Pharma Holdings, Inc. is a holding company. The Company conducts its production, marketing, finance, development and administrative activities through its subsidiary, Hainan Helpson Medical & Biotechnology Co., Ltd. (Helpson) in the People's Republic of China (PRC). It is engaged in the development, manufacture and marketing of pharmaceutical products for human use in connection with various diseases and medical conditions in the PRC. It manufactures pharmaceutical products in the form of dry powder injectables, liquid injectables, tablets, capsules, oral solutions and granules. Its pharmaceutical products are sold on a prescription basis and are approved by the China Food and Drug Administration (the CFDA). The Company manufactured over 20 pharmaceutical products for various diseases and medical indications. It offers products for Central Nervous System (CNS) and Cerebral-Cardiovascular Diseases, Anti-infection and Respiratory Diseases, Digestive Diseases and Others.

微牛提供China Pharma Holdings, Inc.(AMEX-CPHI)的股票价格、实时市场报价、专业分析师评级、深度图表和免费的CPHI股票新闻，以帮助您做出投资决策。

模拟交易：模拟炒股免费实操交易技能。您可用虚拟资金在真实市场环境中零成本、零风险体验交易CPHI股票基本功能。